CLEARANCE FROM DIALYSATE AND EQUILIBRATION OF INTRAPERITONEAL VANCOMYCIN IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引:15
|
作者
NEAL, D
BAILIE, GR
机构
[1] ALBANY COLL PHARM,106 NEW SCOTLAND AVE,ALBANY,NY 12208
[2] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
关键词
D O I
10.2165/00003088-199018060-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article reports on a study of the disposition of loading doses (1g and 15 mg/kg) of vancomycin given intraperitoneally to 6 patients on continuous ambulatory peritoneal dialysis with Gram-positive peritonitis. Dialysate samples were collected every 30 minutes during the first dwell, and serum samples were collected after the first 5 exchanges and after 7 or 14 days. The dialysate concentration/time data were fitted to a monoexponential curve for 4 patients and to a biexponential curve for 2 others. Dialysis clearance was 0.73 ± 0.04 L/h (1g dose) and 0.70 ± 0.23 L/h (15 mg/kg dose). Total body clearance was 0.51 ± 0.36 L/h. Serum concentrations reached 14 to 18 mg/L (15 mg/kg dose) and 6.75 to 24 mg/L (1g dose) at the end of the first dwell. The half-life of equilibration of vancomycin across the peritoneal membrane was 2.5 ± 2.3 hours. Intraperitoneal loading doses of vancomycin produce concomitant serum concentrations in excess of the minimum inhibitory concentrations for susceptible organisms. Administration on a milligram per kilogram basis produces more consistent serum concentrations than using a standard loading dose which is not based on bodyweight. © 1990, Adis Press Limited. All rights reserved.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 50 条
  • [21] VANCOMYCIN PHARMACOKINETICS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS WITH PERITONITIS
    HARFORD, AM
    SICA, DA
    TARTAGLIONE, T
    POLK, RE
    DALTON, HP
    POYNOR, W
    NEPHRON, 1986, 43 (03): : 217 - 222
  • [22] PHARMACOKINETICS OF VANCOMYCIN IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BLEVINS, RD
    HALSTENSON, CE
    SALEM, NG
    MATZKE, GR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 603 - 606
  • [23] DIALYSATE GLUCOSE-ABSORPTION IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
    SANTIAGO, A
    GINSBERG, NS
    FEINFELD, DA
    LYNN, RI
    CLINICAL RESEARCH, 1988, 36 (05): : A805 - A805
  • [24] GLYCATED ALBUMIN IN SERUM AND DIALYSATE OF PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    LAMB, E
    CATTELL, WR
    DAWNAY, A
    CLINICAL SCIENCE, 1993, 84 (06) : 619 - 626
  • [25] A COMPARISON BETWEEN INTRAPERITONEAL CIPROFLOXACIN AND INTRAPERITONEAL VANCOMYCIN AND GENTAMICIN IN THE TREATMENT OF PERITONITIS ASSOCIATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    FRIEDLAND, JS
    IVESON, TJ
    FRAISE, AP
    WINEARLS, CG
    SELKON, JB
    OLIVER, DO
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 : 77 - 81
  • [26] TREATMENT OF PERITONITIS WITH 2 INTRAPERITONEAL (IP) DOSES OF VANCOMYCIN IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) PATIENTS
    BASTANI, B
    WESTERVELT, FB
    FREER, KE
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 229 - 229
  • [27] PERITONITIS WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND CONTINUOUS CYCLING PERITONEAL-DIALYSIS
    WARADY, BA
    CAMPOY, SF
    GROSS, SP
    SEDMAN, AB
    LUM, GM
    JOURNAL OF PEDIATRICS, 1984, 105 (05): : 726 - 730
  • [28] INTRAVENOUS OR INTRAPERITONEAL VANCOMYCIN FOR THE TREATMENT OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ASSOCIATED GRAM-POSITIVE PERITONITIS
    BAILIE, GR
    MORTON, R
    GANGULI, L
    KEANEY, M
    WALDEK, S
    NEPHRON, 1987, 46 (03): : 316 - 318
  • [29] GLUCOSE-UTILIZATION FROM DIALYSATE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    SANTO, NGD
    CAPODICASA, G
    SENATORE, R
    CICCHETTI, T
    CIRILLO, D
    DAMIANO, M
    TORELLA, R
    GIUGLIANO, D
    IMPROTA, L
    GIORDANO, C
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1979, 2 (03): : 119 - 124
  • [30] PERITONEAL TRANSPORT OF VANCOMYCIN IN 4 PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    PANCORBO, S
    COMTY, C
    NEPHRON, 1982, 31 (01): : 37 - 39